Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma

NCT00948922 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Bortezomib
DRUG: Melphalan
PROCEDURE: Autologous Stem Cell Transplant
DRUG: Fludarabine
PROCEDURE: Allogeneic Stem Cell Transplant

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]